Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes

Qiao, Ying, Mondal, Kajari, Trapani, Valentina, Wen, Jiadi, Carpenter, Gillian, Wildin, Robert, Price, E Magda, Gibbons, Richard J, Eichmeyer, Jennifer, Jiang, Ruby, Dupont, Barbara, Martell, Sally, Lewis, Suzanne M E, Robinson, Wendy P, O'Driscoll, Mark, Wolf, Federica I, Zwick, Michael E and Rajcan-Separovic, Evica (2014) Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes. Human mutation, 35 (1). pp. 58-62. ISSN 1098-1004

Full text not available from this repository.

Abstract

A 0.8kb intronic duplication in MAGT1 and a single base pair deletion in the last exon of ATRX were identified using a chromosome X specific microarray and exome sequencing in a family with 5 males demonstrating intellectual disability (ID) and unusual skin findings (e.g. generalized pruritus). MAGT1 is a Mg(2+) transporter previously associated with primary immunodeficiency and ID, while mutations in ATRX cause ATRX-ID syndrome. In patient cells, the function of ATRX was demonstrated to be abnormal based on altered RNA/protein expression, hypomethylation of rDNA, and abnormal cytokinesis. Dysfunction of MAGT1 was reflected in reduced RNA/protein expression and Mg(2+) influx. The mutation in ATRX most likely explains the ID, while MAGT1 disruption could be linked to abnormal skin findings, as normal magnesium homeostasis is necessary for skin health. This work supports observations that multiple mutations collectively contribute to the phenotypic variability of syndromic ID, and emphasizes the importance of correlating clinical phenotype with genomic and cell function analyses. This article is protected by copyright. All rights reserved.

Item Type: Article
Schools and Departments: School of Life Sciences > Sussex Centre for Genome Damage and Stability
Subjects: R Medicine > RB Pathology > RB127 Manifestations of disease
Depositing User: Mark O'Driscoll
Date Deposited: 06 Nov 2013 10:58
Last Modified: 21 Jul 2014 10:02
URI: http://sro.sussex.ac.uk/id/eprint/46950
📧 Request an update